Profiling lethal factor interacting proteins from human stomach using T7 phage display screening

Cardona‑Correa,Albin; Rios‑Velazquez,Carlos

doi:10.3892/mmr.2016.5031

Profiling lethal factor interacting proteins from human stomach using T7 phage display screening

Authors:
- Albin Cardona‑Correa
- Carlos Rios‑Velazquez
View Affiliations

Affiliations: Department of Biology, College of Arts and Sciences, University of Puerto Rico‑Mayagüez, Mayagüez 00681‑9000, PR, USA
Published online on: March 21, 2016 https://doi.org/10.3892/mmr.2016.5031
Pages: 3797-3804
Copyright: © Cardona‑Correa et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The anthrax lethal factor (LF) is a zinc dependent metalloproteinase that cleaves the majority of mitogen-activated protein kinase kinases and a member of NOD-like receptor proteins, inducing cell apoptosis. Despite efforts to fully understand the Bacillus anthracis toxin components, the gastrointestinal (GI) anthrax mechanisms have not been fully elucidated. Previous studies demonstrated gastric ulceration, and a substantial bacterial growth rate in Peyer's patches. However, the complete molecular pathways of the disease that results in tissue damage by LF proteolytic activity remains unclear. In the present study, to identify the profile of the proteins potentially involved in GI anthrax, protein‑protein interactions were investigated using human stomach T7 phage display (T7PD) cDNA libraries. T7PD is a high throughput technique that allows the expression of cloned DNA sequences as peptides on the phage surface, enabling the selection and identification of protein ligands. A wild type and mutant LF (E687A) were used to differentiate interaction sites. A total of 124 clones were identified from 194 interacting‑phages, at both the DNA and protein level, by in silico analysis. Databases revealed that the selected candidates were proteins from different families including lipase, peptidase‑A1 and cation transport families, among others. Furthermore, individual T7PD candidates were tested against LF in order to detect their specificity to the target molecule, resulting in 10 LF‑interacting peptides. With a minimum concentration of LF for interaction at 1 µg/ml, the T7PD isolated pepsin A3 pre‑protein (PAP) demonstrated affinity to both types of LF. In addition, PAP was isolated in various lengths for the same protein, exhibiting common regions following PRALINE alignment. These findings will help elucidate and improve the understanding of the molecular pathogenesis of GI anthrax, and aid in the development of potential therapeutic agents.

View Figures

View References

1	Akbulut A, Akbulut H, Özgüler M, İnci N and Yalçın Ş:: Gastrointestinal anthrax: A case and review of literature. Adv Infect Dis. 2:67–71. 2012. View Article : Google Scholar
2	Sirisanthana T and Brown AE: Anthrax of the gastrointestinal tract. Emerg Infect Dis. 8:649–651. 2002. View Article : Google Scholar : PubMed/NCBI
3	Glomski IJ, Piris-Gimenez A, Huerre M, Mock M and Goossens PL: Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog. 3:e762007. View Article : Google Scholar : PubMed/NCBI
4	Tonry JH, Popov SG, Narayanan A, Kashanchi F, Hakami RM, Carpenter C, Bailey C and Chung MC: In vivo murine and in vitro M-like cell models of gastrointestinal anthrax. Microbes Infect. 15:37–44. 2013. View Article : Google Scholar
5	Iqbal N, Basheer A, Ramesh AN, Vimal J, Mookkappan S, Kanungo R, Anandhalakshmi and Princess I: Gastrointestinal anthrax in coastal south India: A critical alert on a fatal masquerader. JMM Case Rep. 2:e0.0000132015. View Article : Google Scholar
6	Hashemi SA, Azimian A, Nojumi S, Garivani T, Safamanesh S and Ghafouri M: A case of fatal gastrointestinal anthrax in north eastern Iran. Case Rep Infect Dis. 2015:8758292015.PubMed/NCBI
7	Bouzianas DG: Medical countermeasures to protect humans from anthrax bioterrorism. Trends Microbiol. 17:522–528. 2009. View Article : Google Scholar : PubMed/NCBI
8	Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, et al: Crystal structure of the anthrax lethal factor. Nature. 414:229–233. 2001. View Article : Google Scholar : PubMed/NCBI
9	Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD and Vande Woude GF: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 280:734–737. 1998. View Article : Google Scholar : PubMed/NCBI
10	Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev. 22:153–183. 2001.PubMed/NCBI
11	Yang J, Boerm M, McCarty M, Bucana C, Fidler IJ, Zhuang Y and Su B: Mekk3 is essential for early embryonic cardiovascular development. Nat Genet. 24:309–313. 2000. View Article : Google Scholar : PubMed/NCBI
12	Park JM, Greten FR, Li ZW and Karin M: Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 297:2048–2051. 2002. View Article : Google Scholar : PubMed/NCBI
13	Miao EA, Rajan JV and Aderem A: Caspase-1-induced pyroptotic cell death. Immunol Rev. 243:206–214. 2011. View Article : Google Scholar : PubMed/NCBI
14	Sun C, Fang H, Xie T, Auth RD, Patel N, Murray PR, Snoy PJ and Frucht DM: Anthrax lethal toxin disrupts intestinal barrier function and causes systemic infections with enteric bacteria. PloS One. 7:e335832012. View Article : Google Scholar : PubMed/NCBI
15	Liu S, Moayeri M and Leppla SH: Anthrax lethal and edema toxins in anthrax pathogenesis. Trends Microbiol. 22:317–325. 2014. View Article : Google Scholar : PubMed/NCBI
16	Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S, Sastalla I, Leppla SH and Moayeri M: Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog. 8:e10026382012. View Article : Google Scholar : PubMed/NCBI
17	Moayeri M, Sastalla I and Leppla SH: Anthrax and the inflammasome. Microbes Infect. 14:392–400. 2012. View Article : Google Scholar :
18	Lightfoot YL, Yang T, Sahay B, Zadeh M, Cheng SX, Wang GP, Owen JL and Mohamadzadeh M: Colonic immune suppression, barrier dysfunction and dysbiosis by gastrointestinal Bacillus anthracis infection. PloS One. 9:e1005322014. View Article : Google Scholar
19	Baldari CT, Tonello F, Paccani SR and Montecucco C: Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol. 27:434–440. 2006. View Article : Google Scholar : PubMed/NCBI
20	Klimpel KR, Arora N and Leppla SH: Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol. 13:1093–1100. 1994. View Article : Google Scholar : PubMed/NCBI
21	Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment search tool. J Mol Biol. 215:403–410. 1990. View Article : Google Scholar : PubMed/NCBI
22	Pirovano W, Feenstra KA and Heringa J: PRALINETM: A strategy for improved multiple alignment of transmembrane proteins. Bioinformatics. 24:492–497. 2008. View Article : Google Scholar : PubMed/NCBI
23	Hellmich KA, Levinsohn JL, Fattah R, Newman ZL, Maier N, Sastalla I, Liu S, Leppla SH and Moayeri M: Anthrax lethal factor cleaves mouse nlrp1b in both toxin-sensitive and toxin-resistant macrophages. PLoS One. 7:e497412012. View Article : Google Scholar : PubMed/NCBI
24	Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M and Montecucco C: Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun. 248:706–711. 1998. View Article : Google Scholar : PubMed/NCBI
25	Bishop BL, Lodolce JP, Kolodziej LE, Boone DL and Tang WJ: The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection. Biochem Biophys Res Commun. 394:254–259. 2010. View Article : Google Scholar : PubMed/NCBI
26	Menard A, Papini E, Mock M and Montecucco C: The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors. Biochem J. 320:687–691. 1996. View Article : Google Scholar : PubMed/NCBI
27	Kuzmič P, Sun CQ, Zhao ZC and Rich DH: Long range electrostatic effects in pepsin catalysis. Tetrahedron. 47:2519–2534. 1991. View Article : Google Scholar
28	Kandadi MR, Hua Y, Ma H, Li Q, Kuo SR, Frankel AE and Ren J: Anthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism. PloS One. 5:e133352010. View Article : Google Scholar : PubMed/NCBI
29	Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al: Towards a knowledge-based human protein atlas. Nat Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
30	Durand DB, Shaw JP, Bush MR, Replogle RE, Belagaje R and Crabtree GR: Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol. 8:1715–1724. 1988. View Article : Google Scholar : PubMed/NCBI
31	Fang H, Cordoba-Rodriguez R, Lankford CS and Frucht DM: Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cells. J Immunol. 174:4966–4971. 2005. View Article : Google Scholar : PubMed/NCBI
32	Palmgren MG and Nissen P: P-type ATPases. Annu Rev Biophys. 40:243–266. 2011. View Article : Google Scholar : PubMed/NCBI
33	van Veen S, Sørensen DM, Holemans T, Holen HW, Palmgren MG and Vangheluwe P: Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders. Front Mol Neurosci. 7:482014. View Article : Google Scholar : PubMed/NCBI
34	Brunori M, Antonini G, Malatesta F, Sarti P and Wilson MT: Cytochrome-c oxidase. Subunit structure and proton pumping. Eur J Biochem. 169:1–8. 1987. View Article : Google Scholar : PubMed/NCBI
35	Chung MC, Narayanan A, Popova TG, Kashanchi F, Bailey CL and Popov SG: Bacillus anthracis derived nitric oxide induces protein S-nitrosylation contributing to macrophage death. Biochem Biophys Res Commun. 430:125–130. 2013. View Article : Google Scholar
36	Harada T, Iwai A and Miyazaki T: Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction. Apoptosis. 15:1247–1255. 2010. View Article : Google Scholar : PubMed/NCBI
37	Morinaga T, Enomoto A, Shimono Y, Hirose F, Fukuda N, Dambara A, Jijiwa M, Kawai K, Hashimoto K, Ichihara M, et al: GDNF-inducible zinc finger protein 1 is a sequence-specific transcriptional repressor that binds to the HOXA10 gene regulatory region. Nucleic Acids Res. 33:4191–4201. 2005. View Article : Google Scholar : PubMed/NCBI
38	Brown RS, Sander C and Argos P: The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett. 186:271–274. 1985. View Article : Google Scholar : PubMed/NCBI
39	Xie T, Sun C, Uslu K, Auth RD, Fang H, Ouyang W and Frucht DM: A new murine model for gastrointestinal anthrax infection. PloS One. 8:e669432013. View Article : Google Scholar : PubMed/NCBI
40	Burgos R: Isolation of interacting peptides to Bacillus anthracis lethal toxin (LF) by T7 phage display (unpublished Master's dissertation). University of Puerto Rico; 2010